Create an Account
  1. Home
  2. Topics
  3. Kidney Disease
  4. Videos

Kidney Disease

65-80 of 145

  • Primary care as gatekeeper in CKD and the need for collaboration with nephrologistsPrimary care as gatekeeper in CKD and the need for collaboration with nephrologists
    Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification
    Primary care as gatekeeper in CKD and the need for collaboration with nephrologists
    • Prof. Kamlesh Khunti, MD
      Prof. Kamlesh Khunti, MD

      Prof. Kamlesh Khunti, MD

  • Discussion Preventing CKD in patients with diabetes Exploring the current and future role of GLPRADiscussion Preventing CKD in patients with diabetes Exploring the current and future role of GLPRA
    Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
    Discussion - Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
    • Prof. Johannes Mann, MD
      Prof. Johannes Mann, MD

      Prof. Johannes Mann, MD

    • Prof. Filip Knop, MD, PhD
      Prof. Filip Knop, MD, PhD

      Prof. Filip Knop, MD, PhD

    • Prof. Katherine Tuttle, MD
      Prof. Katherine Tuttle, MD

      Prof. Katherine Tuttle, MD

  • Why is early screening and risk identification of CKD in diabetes importantWhy is early screening and risk identification of CKD in diabetes important
    Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification
    Why is early screening and risk identification of CKD in diabetes important?
    • Rikke Borg, MD, PhD
      Rikke Borg, MD, PhD

      Rikke Borg, MD, PhD

  • Discussion Rethinking the role of nephrologists in prevention of CKD The opportunity of early risk identificationDiscussion Rethinking the role of nephrologists in prevention of CKD The opportunity of early risk identification
    Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification
    Discussion - Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification
    • Prof. Christoph Wanner
      Prof. Christoph Wanner

      Prof. Christoph Wanner

    • Rikke Borg, MD, PhD
      Rikke Borg, MD, PhD

      Rikke Borg, MD, PhD

    • Prof. Kamlesh Khunti, MD
      Prof. Kamlesh Khunti, MD

      Prof. Kamlesh Khunti, MD

  • Benefits and evolving insights on SGLTi in the spectrum of LVEFBenefits and evolving insights on SGLTi in the spectrum of LVEF
    When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
    Benefits and evolving insights on SGLT2i in the spectrum of LVEF
    • Prof. Carolyn Lam, MD
      Prof. Carolyn Lam, MD

      Prof. Carolyn Lam, MD

  • Barriers for preventing CKD in patients with diabetes Barriers for preventing CKD in patients with diabetes
    Rethinking the role of nephrologists in prevention of CKD - The opportunity of early risk identification
    Barriers for preventing CKD in patients with diabetes
    • Prof. Christoph Wanner
      Prof. Christoph Wanner

      Prof. Christoph Wanner

  • The clinical challenges of initiating guideline recommended therapy in HFThe clinical challenges of initiating guideline recommended therapy in HF
    When to start using SGLT2i in HFrEF? Initiating guideline-recommended treatment options
    The clinical challenges of initiating guideline recommended therapy in HF
    • Prof. John McMurray, MD
      Prof. John McMurray, MD

      Prof. John McMurray, MD

  • Ciculating ketonse bodies in acute HF treated with SGLTiCiculating ketonse bodies in acute HF treated with SGLTi
    ESC Heart Failure 2022
    Ciculating ketonse bodies in acute HF treated with SGLT2i
    • Suzanne Voorrips, MD
      Suzanne Voorrips, MD

      Suzanne Voorrips, MD

  • Which patients with CKD and diabetes will benefit from management with GLPRAWhich patients with CKD and diabetes will benefit from management with GLPRA
    Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
    Which patients with CKD and diabetes will benefit from management with GLP-1RA?
    • Prof. Katherine Tuttle, MD
      Prof. Katherine Tuttle, MD

      Prof. Katherine Tuttle, MD

  • What is relevant for nephrology with regard to GLPRA in CVDWhat is relevant for nephrology with regard to GLPRA in CVD
    Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
    What is relevant for nephrology with regard to GLP-1RA in CVD?
    • Prof. Filip Knop, MD, PhD
      Prof. Filip Knop, MD, PhD

      Prof. Filip Knop, MD, PhD

  • New insights and guidelines for the management of CKD and diabetesNew insights and guidelines for the management of CKD and diabetes
    Preventing CKD in patients with diabetes - Exploring the current and future role of GLP-1RA
    New insights and guidelines for the management of CKD and diabetes
    • Prof. Johannes Mann, MD
      Prof. Johannes Mann, MD

      Prof. Johannes Mann, MD

  • Which patients benefit from potassium bindersWhich patients benefit from potassium binders
    3 Things a cardiologist needs to know about potassium binders
    Which patients benefit from potassium binders?
    • Kevin Damman, MD, PhD
      Kevin Damman, MD, PhD

      Kevin Damman, MD, PhD

  • Dialogue on how to overcome clinical inertia with regard to SGLTiDialogue on how to overcome clinical inertia with regard to SGLTi
    Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia
    Dialogue on how to overcome clinical inertia with regard to SGLT2i
    • Prof. Melanie Davies, MD
      Prof. Melanie Davies, MD

      Prof. Melanie Davies, MD

    • Prof. Nikolaus Marx, MD
      Prof. Nikolaus Marx, MD

      Prof. Nikolaus Marx, MD

  • Introduction on tackling cardiorenal risk in diabetesIntroduction on tackling cardiorenal risk in diabetes
    Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia
    Introduction on tackling cardiorenal risk in diabetes
    • Prof. Melanie Davies, MD
      Prof. Melanie Davies, MD

      Prof. Melanie Davies, MD

  • Symposium on the role of SGLTi in tackling cardiorenal risk in diabetesSymposium on the role of SGLTi in tackling cardiorenal risk in diabetes
    Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia
    Symposium on the role of SGLT2i in tackling cardiorenal risk in diabetes
    • Prof. Melanie Davies, MD
      Prof. Melanie Davies, MD

      Prof. Melanie Davies, MD

    • Prof. Nikolaus Marx, MD
      Prof. Nikolaus Marx, MD

      Prof. Nikolaus Marx, MD

  • SGLTi Overview of recent trials and guideline recommendationsSGLTi Overview of recent trials and guideline recommendations
    Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia
    SGLT2i: Overview of recent trials and guideline recommendations
    • Prof. Nikolaus Marx, MD
      Prof. Nikolaus Marx, MD

      Prof. Nikolaus Marx, MD

5/10
LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying PACE-CME…
    but how about a more personalized experience?

    Register for free